3Galano G, Caputo M, Tecce MF, et al. Efficacy and tolerability of vinorelbine in the cancer therapy[J]. Curr Drug Saf, 2011, 6(3): 185-193.
4Bahadori F, Topcu G, Eroqiu MS, et al. A new lipid-based nano formulation of vinorelbine[J]. AAPS Pharm Sci Tech, 2014, 15(5): 1138-1148.
5Wakelee HA, Middleton G, Dunlop D, et al. A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)[J]. Cancer Chemother Pharmacol, 2012, 69(3): 815-824.
6Shi JF, Sun MG, Li XY, et al. A combination of targeted sunitinib liposomes and targeted vinorelbine liposomes for treating invasive breast cancer[J]. J Biomed Nanatechnol, 2015, 11(9): 1568-1582.
